HomeCompareCDXC vs GBDC

CDXC vs GBDC: Dividend Comparison 2026

CDXC yields 25.41% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.75M in total portfolio value· pulled ahead in Year 3
10 years
CDXC
CDXC
● Live price
25.41%
Share price
$7.87
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$101.2K
Annual income
$11,579.48
Full CDXC calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — CDXC vs GBDC

📍 GBDC pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDXCGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDXC + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDXC pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDXC
Annual income on $10K today (after 15% tax)
$2,160.10/yr
After 10yr DRIP, annual income (after tax)
$9,842.56/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,973,281.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDXC + GBDC for your $10,000?

CDXC: 50%GBDC: 50%
100% GBDC50/50100% CDXC
Portfolio after 10yr
$10.48M
Annual income
$8,231,156.66/yr
Blended yield
78.57%
📊

Analyst Conviction Gap

Where Wall Street is split right now

CDXC
Analyst Ratings
6
Buy
2
Hold
Consensus: Buy
Altman Z
11.8
Piotroski
5/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDXC buys
0
GBDC buys
0
No recent congressional trades found for CDXC or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDXCGBDC
Forward yield25.41%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$101.2K$20.85M
Annual income after 10y$11,579.48$16,450,733.83
Total dividends collected$64.5K$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: CDXC vs GBDC ($10,000, DRIP)

YearCDXC PortfolioCDXC Income/yrGBDC PortfolioGBDC Income/yrGap
1$13,241$2,541.30$12,492$1,791.70+$749.00CDXC
2$17,313$3,144.86$16,527$3,160.58+$786.00CDXC
3← crossover$22,368$3,842.92$23,588$5,904.90$1.2KGBDC
4$28,574$4,640.12$37,141$11,901.65$8.6KGBDC
5$36,114$5,539.72$66,205$26,463.38$30.1KGBDC
6$45,185$6,543.46$137,452$66,612.65$92.3KGBDC
7$56,000$7,651.51$342,372$195,298.53$286.4KGBDC
8$68,782$8,862.44$1,053,292$686,954.33$984.5KGBDC
9$83,770$10,173.24$4,111,439$2,984,416.95$4.03MGBDC
10$101,213$11,579.48$20,849,974$16,450,733.83$20.75MGBDC

CDXC vs GBDC: Complete Analysis 2026

CDXCStock

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

Full CDXC Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CDXC vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDXC vs SCHDCDXC vs JEPICDXC vs OCDXC vs KOCDXC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.